Schedule 13G
Explanatory Note:
This Schedule 13G is filed jointly on behalf of Jeremy M. Sclar, Crocker Mountain LLC, a Maine limited liability company (“Crocker Mountain”), and the Jeremy M. Sclar 2012 Irrevocable Family Trust (the “JS Trust,” and collectively with Mr. Sclar and Crocker Mountain, the “Reporting Persons”), pursuant to Rule 13d-1(c). Prior to the effective date of the registration of the Issuer’s common shares, no par value per share (“Common Shares”), pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, in July of 2022, (i) Mr. Sclar acquired 65,000 Common Shares, which appear to represent approximately 3,900,000 Common Shares prior to a 60:1 stock split (the “Stock Split”) of the Issuer that occurred in June 2022, (ii) Crocker Mountain acquired (a) 20,449,980 Common Shares, representing 340,833 Common Shares following the Stock Split, (b) 9,000,000 Series 1 Preferred Shares (“Series 1 Preferred Shares”) of the Issuer, each initially convertible into one Common Share in accordance with the terms of the Series 1 Preferred Shares and, as a result of the Stock Split, now convertible into an aggregate of 150,000 Common Shares and (c) 5,112,480 warrants to purchase Common Shares, representing 85,208 warrants to purchase Common Shares following the Stock Split, each exercisable to purchase one Common Share and (iii) the JS Trust acquired 9,000,000 Series 1 Preferred Shares, each initially convertible into one Common Share in accordance with the terms of the Series 1 Preferred Shares and, as a result of the Stock Split, now convertible into an aggregate of 150,000 Common Shares. On October 11, 2022, the JS Trust acquired 104,869 Common Shares in a private placement conducted by the Issuer. Such acquisition, when added to all other acquisitions of securities of the same class during the 12 months immediately preceding the date of such acquisition, aggregates to two percent (2%) or less of the class of such securities. Accordingly, the Reporting Persons are filing this Schedule 13G pursuant to Rule 13d-1(d).
Item 1.
The name of the Issuer is ProMIS Neurosciences Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
The principal executive offices of the Issuer are located at Suite 200, 1920 Yonge Street, Toronto, Ontario.
Item 2.
This statement is filed by the Reporting Persons.
| (b) | Address of the Principal Office or, if none, residence |
The address of the Reporting Persons is 33 Boylston Street, Suite 3000, Chestnut Hill, MA 02467.
Mr. Sclar is a citizen of the United States of America. Crocker Mountain is a Maine limited liability company. The JS Trust is a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts.
| (d) | Title of Class of Securities |
The Schedule 13G statement relates to Common Shares of the Issuer.
The CUSIP number for the Common Stock is 74346M117.